The NT-proBNP-to-albumin ratio (NTAR) emerges as a potentially clinically relevant composite biomarker that reflects both cardiac overload and systemic dysfunction in patients with chronic heart failure (CHF). This evidence concerns the gene ALB and congestive heart failure.